Manage Your Liver
Q:

‘ALT Focused Therapy’: A new approach to manage chronic liver diseases

‘ALT Focused Therapy’: A new approach to manage chronic liver diseases
A:

The number of deaths caused by liver cancer is constantly increasing; in 2012, liver cancer has caused more deaths than any other cancers globally. The prevalence and severity liver disease is obvious. To liver disease patients, nothing is more worrying than chronic inflammation and the possibility of developing more serious liver diseases.

 

To change the situation and treat liver disease more effectively, other than developing new medicine, reinforcing protection work and maintaining a healthy lifestyle, we should also understand the weaknesses of the current treatment and make adjustments accordingly. Let’s look at the illustration below:

 

 

We can see that the treatment process now aims to eliminate the cause of liver damage first (e.g. Hepatitis virus, fat, alcohol, etc.). Then, the liver’s self-repair ability allows liver cells to recover  normal liver function to resume. The biggest problem and weakness of this approach is the long period of liver cell injury (the red bar). In addition, the success rate of most drugs is low while the cost is high; not to mention the long treatment time and severe side effects. In other words, the current treatment approach lacks focus on the recovery process. Chronic liver injury  causes liver fibrosis, cirrhosis and increases the risk of liver cancer greatly.

 

In view of this, chronic liver disease patients should focus on enhancing liver cell recovery and shortening the time with liver damage. We therefore suggest ‘ALT Focused Therapy’:

 

 

The major advantage of ‘ALT Focused Therapy’ is that the most urgent and dangerous problem is tackled first. By first stopping long term injury to liver cells, liver fibrosis and cirrhosis can be prevented, and the chance of liver cancer can be reduced. After liver function is improved, patients can then carry out drug treatment to eliminate the harmful substances in their body gradually. When compared with the current approach, ‘ALT Focused Therapy’ can help patients greatly reduce the time with liver injury (the red bar is shortened significantly).  

 

To carry out ALT Focused Therapy, YHK is a safe and effective formula that can help liver cell recovery. Clinical Research shows that YHK can effectively normalise ALT level and improve liver health quickly (within 10-30 days). It is an ideal options for liver patients who wish to quickly repair their liver cells and improve liver function.

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Tags:
hepatitis Bhepatitis CALT Focused Therapy
Related Questions
A:
Research and developing our products has always been a big part of our work. Kyotsujigyo has worked with a number of well established organisations and universities in the past, including the University of Sao Paulo, GAIA Age-Management Foundation, The University of Western Ontario, University of Virginia, Yanaihara Research Institute,  Harada Hospital (Japan) and others.    In 2016 Kyotsujigyo has corporate with the National Key Research Institute in Hong K
A:
NASH is inflammation in the liver developed from accumulated fat in the organ, also known as fatty liver. NASH damages liver cells and liver function, which results in elevated ALT liver enzyme level.    As there are no approved treatments for NASH, the standard recommendation for patients is to lose weight only. However this doesn’t work for everyone so if you are struggling to find a way to stop NASH, please read on.   Wha
Hit Questions
A:
Research and developing our products has always been a big part of our work. Kyotsujigyo has worked with a number of well established organisations and universities in the past, including the University of Sao Paulo, GAIA Age-Management Foundation, The University of Western Ontario, University of Virginia, Yanaihara Research Institute,  Harada Hospital (Japan) and others.    In 2016 Kyotsujigyo has corporate with the National Key Research Institute in Hong K
A:
NASH is inflammation in the liver developed from accumulated fat in the organ, also known as fatty liver. NASH damages liver cells and liver function, which results in elevated ALT liver enzyme level.    As there are no approved treatments for NASH, the standard recommendation for patients is to lose weight only. However this doesn’t work for everyone so if you are struggling to find a way to stop NASH, please read on.   Wha
A:
In 2010, some 4.7 million people aged 65 years or older lived with Alzheimer's disease in the US.   Alzheimer’s is a common brain disease that causes progressive brain cell death that happens over a course of time. It will also cause a shrink in brain size as the tissue has progressively fewer nerve cells and connections. Alzheimer’s is thought to be caused by Protein Plaques building up in the brain cells, these Plaques are found between the dying cel
A:
There are between 10 to 15 million patients in the U.S. with NASH, and among these patients, one-fifth to one-fourth are at risk for cirrhosis or chronic liver damage.   The major characteristic of NASH is fat in the liver, along with inflammation and damage. NASH can be severe and can lead to cirrhosis. The number of NASH cirrhosis patients is currently on the rise, and it is predicted (NAFLD & NASH) to be the number 1 cause of liver transplants by 2020. [1] Ther
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Have
Questions?
Sumbit your question
to us for profeessional answers!
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Looking for help? Ask our customer support team!
Contact Us